(via TheNewswire)
The news release issued by Advancements follows:
“An upcoming Segment ofAdvancementswill Explore the Future of Breast Imaging
Learn how developments in technology are improving the outcomes of breast cancer.
Jupiter, FL—An upcoming segment ofAdvancements with
In this episode, viewers will learn about the increasing rates of breast cancer, which in recent years has surpassed lung cancer as the most common form. Audiences will learn how developments in CT imaging technology are providing more accurate detection and diagnosis of breast cancers.
Viewers will learn about Izotropic Corporation’s IzoView Breast CT imaging platform, which produces high resolution breast images in true 3D with low radiation dose levels.
“IzoView has the potential to revolutionize breast imaging as we know it”, said Dr.
In addition, the show will discover what makes the platform ideal for imaging patients with dense breast tissue.
“One 10 second scan acquires approximately 500 images. The process is quick and removes the need for painful breast compression or continual technician breast handling, providing a more comfortable patient experience,”said
About
For more information, visithttps://izocorp.com/
About
Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies.Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.
Backed by experts in various fields,
For more information, please visitwww.AdvancementsTV.comor call 866-496-4065.”
ON BEHALF OF THE BOARD
Investor Relations Contact:
Mr.
Email:info@izocorp.com
Toll Free: 1-833-IZOCORP ext.1
Media Inquiries Contact:
Ms.
Email:jaclyn@izocorp.com
Toll Free: 1-833-IZOCORP ext.3
About
More information about
Forward-Looking Statements
This document may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions, projections, and expectations of the Company's management, business, and its knowledge of the relevant market and economic environment in which it operates. The Company has tried, where possible, to identify such information and statements by using words such as "anticipate," "believe," "envision," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target,""potential," "will," "would," "could," "should," "continue," "contemplate" and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words.
These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company's activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView is not yet approved for sale.
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source